Moskal_2011_Neurosci.Biobehav.Rev_35_1982

Reference

Title : A novel NMDA receptor glycine-site partial agonist, GLYX-13, has therapeutic potential for the treatment of autism - Moskal_2011_Neurosci.Biobehav.Rev_35_1982
Author(s) : Moskal JR , Burgdorf J , Kroes RA , Brudzynski SM , Panksepp J
Ref : Neurosci Biobehav Rev , 35 :1982 , 2011
Abstract : Moskal_2011_Neurosci.Biobehav.Rev_35_1982
ESTHER : Moskal_2011_Neurosci.Biobehav.Rev_35_1982
PubMedSearch : Moskal_2011_Neurosci.Biobehav.Rev_35_1982
PubMedID: 21718719

Related information

Citations formats

Moskal JR, Burgdorf J, Kroes RA, Brudzynski SM, Panksepp J (2011)
A novel NMDA receptor glycine-site partial agonist, GLYX-13, has therapeutic potential for the treatment of autism
Neurosci Biobehav Rev 35 :1982

Moskal JR, Burgdorf J, Kroes RA, Brudzynski SM, Panksepp J (2011)
Neurosci Biobehav Rev 35 :1982